Periodic Reporting for period 1 - TRACE-AD (Tracking the Effects of Amyloid and Tau Pathology on Brain Systems and Cognition in Early Alzheimer’s Disease)

Alzheimer’s disease is a tremendous burden for individual patients, relatives and the health care system. Despite intensive research efforts and drug development, there are still no therapies that have been shown to slow down or stop the disease in a phase 3 trial. So far...